These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34981827)

  • 21. COVID-19 vaccines and the role of other potential allergenic components different from PEG. A reply to: "Other excipients than PEG might cause serious hypersensitivity reactions in COVID-19 vaccines".
    Cabanillas B; Akdis CA; Novak N
    Allergy; 2021 Jun; 76(6):1943-1944. PubMed ID: 34128563
    [No Abstract]   [Full Text] [Related]  

  • 22. Reply to: "Comment on "Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?"".
    Bril F; Fettig DM
    J Hepatol; 2021 Oct; 75(4):996-997. PubMed ID: 34146650
    [No Abstract]   [Full Text] [Related]  

  • 23. Reply to: Before attributing encephalomyelitis to SARS-CoV-2 vaccinations exclude differentials.
    Kania K; Ambrosius W; Tokarz Kupczyk E; Kozubski W
    Ann Clin Transl Neurol; 2021 Nov; 8(11):2224. PubMed ID: 34636495
    [No Abstract]   [Full Text] [Related]  

  • 24. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. Reply.
    Barda N; Dagan N; Balicer RD
    N Engl J Med; 2021 May; 384(20):1970. PubMed ID: 33882227
    [No Abstract]   [Full Text] [Related]  

  • 25. COVID-19 vaccine platforms: Delivering on a promise?
    Verdecia M; Kokai-Kun JF; Kibbey M; Acharya S; Venema J; Atouf F
    Hum Vaccin Immunother; 2021 Sep; 17(9):2873-2893. PubMed ID: 34033528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons. Reply.
    Meaney-Delman DM; Ellington SR; Shimabukuro TT
    N Engl J Med; 2021 Oct; 385(16):1536. PubMed ID: 34496198
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluating COVID-19 Vaccine-Related Messenger RNA in Breast Milk-Reply.
    Golan Y; Flaherman VJ; Gaw SL
    JAMA Pediatr; 2022 Jan; 176(1):100-101. PubMed ID: 34661610
    [No Abstract]   [Full Text] [Related]  

  • 28. Reply to the letter to the editor: "impact of SARS-CoV-2 vaccines on the nervous system".
    Corrêa DG; Hygino da Cruz LC
    Clin Imaging; 2022 Feb; 82():5-6. PubMed ID: 34763264
    [No Abstract]   [Full Text] [Related]  

  • 29. SARS-CoV-2 vaccines are not free of neurological side effects.
    Finsterer J; Scorza FA
    Acta Neurol Scand; 2021 Jul; 144(1):109-110. PubMed ID: 34002379
    [No Abstract]   [Full Text] [Related]  

  • 30. Reply to "PEG skin testing for COVID-19 allergy".
    Banerji A; Phillips E; Saff R; Wickner PG; Robinson LB; Wolfson AR; Williams P; Khan DA; Blumenthal KG
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1765-1766. PubMed ID: 33838846
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to professionally responsible COVID-19 vaccination counseling.
    Chervenak FA; McCullough LB; Bornstein E; Johnson L; Katz A; McLeod-Sordjan R; Nimaroff M; Rochelson BL; Tekbali A; Warman A; Williams K; Grünebaum A
    Am J Obstet Gynecol; 2021 Sep; 225(3):355-356. PubMed ID: 34118199
    [No Abstract]   [Full Text] [Related]  

  • 32. Immune imprinting and SARS-CoV-2 vaccine design.
    Wheatley AK; Fox A; Tan HX; Juno JA; Davenport MP; Subbarao K; Kent SJ
    Trends Immunol; 2021 Nov; 42(11):956-959. PubMed ID: 34580004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 vaccines and appearance of SARS-CoV-2 variants. Reflecting on the case of Mexico.
    Díaz-Quiñónez JA
    Gac Med Mex; 2021; 157(2):119-120. PubMed ID: 34270523
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply: Coronavirus disease 2019 vaccines in pregnancy.
    Craig AM; Hughes BL; Swamy GK
    Am J Obstet Gynecol MFM; 2021 May; 3(3):100337. PubMed ID: 33621715
    [No Abstract]   [Full Text] [Related]  

  • 35. The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?
    Hossain MK; Hassanzadeganroudsari M; Apostolopoulos V
    Expert Rev Vaccines; 2021 Jun; 20(6):635-638. PubMed ID: 33896316
    [No Abstract]   [Full Text] [Related]  

  • 36. Mandatory Coronavirus Disease 2019 Vaccine for Children?-Reply.
    Opel DJ; Diekema DS; Ross LF
    JAMA Pediatr; 2021 May; 175(5):534. PubMed ID: 33555288
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2.
    Tostanoski LH; Gralinski LE; Martinez DR; Schaefer A; Mahrokhian SH; Li Z; Nampanya F; Wan H; Yu J; Chang A; Liu J; McMahan K; Ventura JD; Dinnon KH; Leist SR; Baric RS; Barouch DH
    J Virol; 2021 Nov; 95(23):e0097421. PubMed ID: 34523968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 vaccines and decreased transmission of SARS-CoV-2.
    Vitiello A; Ferrara F; Troiano V; La Porta R
    Inflammopharmacology; 2021 Oct; 29(5):1357-1360. PubMed ID: 34279767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Update on COVID-19 in 2021].
    Zhou M; Qu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jan; 45(1):67-71. PubMed ID: 35000308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 vaccine anaphylaxis: IgE, complement or what else? A reply to: "COVID-19 vaccine anaphylaxis: PEG or not?".
    Cabanillas B; Akdis CA; Novak N
    Allergy; 2021 Jun; 76(6):1938-1940. PubMed ID: 34128561
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.